Home
Finance
Companies
Industry
Market

NASDAQ:ENLV

Market Analysts see Enlivex Therapeutics Ltd [ENLV] gaining to $33. Time to buy?

November 25, 2025

Annabelle Farmer

Enlivex Therapeutics Ltd [NASDAQ: ENLV] gained 13.74% on the last trading session, reaching $1.02 price per share at the time. ...

most recent

Companies

For Keycorp [KEY], Analyst sees a rise to $20. What next?

Market

Market Analysts see Enlivex Therapeutics Ltd [ENLV] gaining to $33. Time to buy?

Industry

Boston Scientific Corp [BSX] Revenue clocked in at $19.35 billion, up 8.73% YTD: What’s Next?

Finance

Chevron Corp [CVX] moved down -0.15: Why It’s Important

Companies

why Lam Research Corp [LRCX] is a Good Choice for Investors After New Price Target of $163.31

Market

JD.com Inc ADR [JD] Stock trading around $29.06 per share: What’s Next?

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled